Literature DB >> 29968117

KIRs gene content diversity in Iranians with urothelial bladder cancer.

Elham Jamali1, Shaghik Barani2, Fahimeh Yousefinejad1, Ali Ariafar3, Ghoalm Reza Talei4, Abbas Ghaderi5,6.   

Abstract

Natural killer cells (NK) are the first arm of the innate immune system in defense against tumor and infection. 16 distinct Killer-cell immunoglobulin-like receptors (KIRs) are involved in orchestrating NK cell function. The KIR family contains 14 genes and 2 pseudogenes. Six of these receptors are activating (aKIR) and the remaining receptors are inhibitory KIRs (iKIR), that interact with MHC-I molecules; producing signals which stop NK cell function. In the current study, we have investigated the genomic diversity of KIRs and determining the A and B haplotypes as well as Bx subsets in 119 patients with bladder cancer and 200 healthy controls to find out if there is an association between KIR system and susceptibility to bladder cancer. Polymerase chain reaction with sequence specific primers (SSP-PCR) typing system was used to determine the KIR gene profile. The results implicated decreased frequency of inhibitory KIR2DL2 and activating KIR2DS2 while increased frequency of CxT4 genotypes in patients compared with healthy controls. Among Bx subsets, the CxT4 gene cluster is more frequent in bladder cancer patients compared to controls. Our results provide a conclusion that KIR2S2 and KIR2L2 may play a protective role against bladder cancer development while the CxT4 gene cluster may underlie susceptibility to bladder cancer in Iranian population.

Entities:  

Keywords:  Bladder cancer; Killer immunoglobulin like receptors (KIRs); Natural killer cell; Polymerase chain reaction with sequence specific primers (PCR–SSP)

Mesh:

Substances:

Year:  2018        PMID: 29968117     DOI: 10.1007/s11033-018-4221-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  28 in total

1.  Association of killer cell immunoglobulin-like receptors with scleroderma.

Authors:  T Momot; S Koch; N Hunzelmann; T Krieg; K Ulbricht; R E Schmidt; T Witte
Journal:  Arthritis Rheum       Date:  2004-05

2.  KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians.

Authors:  Shaghik Barani; Bijan Khademi; Elham Ashouri; Abbas Ghaderi
Journal:  Hum Immunol       Date:  2018-02-09       Impact factor: 2.850

Review 3.  Epidemiology and risk factors of urothelial bladder cancer.

Authors:  Maximilian Burger; James W F Catto; Guido Dalbagni; H Barton Grossman; Harry Herr; Pierre Karakiewicz; Wassim Kassouf; Lambertus A Kiemeney; Carlo La Vecchia; Shahrokh Shariat; Yair Lotan
Journal:  Eur Urol       Date:  2012-07-25       Impact factor: 20.096

4.  Human diversity in killer cell inhibitory receptor genes.

Authors:  M Uhrberg; N M Valiante; B P Shum; H G Shilling; K Lienert-Weidenbach; B Corliss; D Tyan; L L Lanier; P Parham
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

5.  HLA-Cw polypmorphism and killer cell immunoglobulin-like receptor (KIR) gene analysis in Korean colorectal cancer patients.

Authors:  Hyung-Jin Kim; Hae-Baeg Choi; Jung-Pil Jang; In-Cheol Baek; Eun-Jeong Choi; Miyoung Park; Tai-Gyu Kim; Seong-Taek Oh
Journal:  Int J Surg       Date:  2014-07-04       Impact factor: 6.071

6.  Activating KIR2DS5 receptor is a risk for thyroid cancer.

Authors:  Elham Ashouri; Mohammad Hossein Dabbaghmanesh; Soodeh Rowhanirad; Marzieh Bakhshayeshkaram; Gholamhossein Ranjbar Omrani; Abbas Ghaderi
Journal:  Hum Immunol       Date:  2012-07-23       Impact factor: 2.850

7.  Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Authors:  Sarah Cooley; Elizabeth Trachtenberg; Tracy L Bergemann; Koy Saeteurn; John Klein; Chap T Le; Steven G E Marsh; Lisbeth A Guethlein; Peter Parham; Jeffrey S Miller; Daniel J Weisdorf
Journal:  Blood       Date:  2008-10-22       Impact factor: 22.113

Review 8.  Bladder cancer, a review of the environmental risk factors.

Authors:  Silvia Letašiová; Alžbeta Medve'ová; Andrea Šovčíková; Mária Dušinská; Katarína Volkovová; Claudia Mosoiu; Alena Bartonová
Journal:  Environ Health       Date:  2012-06-28       Impact factor: 5.984

9.  Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci.

Authors:  Mary Carrington; Sophia Wang; Maureen P Martin; Xiaojiang Gao; Mark Schiffman; Jie Cheng; Rolando Herrero; Ana Cecilia Rodriguez; Robert Kurman; Rodrigue Mortel; Peter Schwartz; Andrew Glass; Allan Hildesheim
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

Review 10.  The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?

Authors:  Danillo G Augusto
Journal:  Front Genet       Date:  2016-06-28       Impact factor: 4.599

View more
  2 in total

1.  Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.

Authors:  Elham Ashouri; Karan Rajalingam; Shaghik Barani; Shirin Farjadian; Abbas Ghaderi; Raja Rajalingam
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

2.  Expression of Killer Immunoglobulin Receptor Genes among HIV-Infected Individuals with Non-AIDS Comorbidities.

Authors:  Farouk F Abou Hassan; Mirna Bou Hamdan; Khalil El Asmar; Nada M Melhem
Journal:  J Immunol Res       Date:  2022-01-12       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.